Recombinant Human LR3 IGF-1, G

更高活性——植物源重组人IGF-1融合蛋白

，并提高其生物活性，与普通的IGF-1或者LR3 IGF-1相比，OsrIGF-1的稳定性更高。同时，在GMP条件下生产的OsrIGF-1能保障批次间完全无差异，为实验和生产带来更高的保障。同时，OsrIGF-1批次生产可达克级别，源于高表达量的水稻胚乳平台，以满足大规模生产所需。通过实验验证，OsrIGF-1效能为人胰岛素的2000倍左右，活性与longR3相当，其在培养基中5μg/L的添加量对细胞增殖的效果好于人胰岛素10mg/L的添加量，大大减少了胰岛素的用量，降低生产成本。并且OsrIGF

rAAV Vector Product Characterization and Stability Studies

Recombinant adeno-associated viral (rAAV) vectors mediate the safe and long-term correction of genetic diseases following a single administration. Preclinical studies in animal models and human trials have shown rAAV vector persistence

The Adjuvant MF59: A 10-Year Perspective Gary Ott, Ramachandran Radhakrishnan,

Over the last decade, advances in subunit vaccine technology, achieved in many cases with recombinant DNA techniques, have created a dramatic increase in demand for vaccine adjuvants which can help to ellicit protective responses from subunit